NCT06771336

Brief Summary

The purpose of this study is to describe the standard of care pathway of patients treated by free bone flap for facial mandibullar or maxillar reconstruction after surgery for head and neck cancers.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
44mo left

Started Sep 2025

Longer than P75 for all trials

Geographic Reach
1 country

9 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress16%
Sep 2025Dec 2029

First Submitted

Initial submission to the registry

January 7, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 13, 2025

Completed
8 months until next milestone

Study Start

First participant enrolled

September 3, 2025

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2029

Last Updated

September 22, 2025

Status Verified

September 1, 2025

Enrollment Period

4.2 years

First QC Date

January 7, 2025

Last Update Submit

September 17, 2025

Conditions

Keywords

Mandibullar or maxillar reconstructionCare pathwayFree bone flapMedico-economic study

Outcome Measures

Primary Outcomes (1)

  • Description of the standard of care pathway of patients treated by free bone flap for facial mandibullar or maxillar reconstruction after surgery for head and neck cancers

    The primary outcome measure is a composite endpoint consisting of the description of care pathways based on care consumption (scheduled and unscheduled hospitalizations and consultations, medical procedures and medications). The study of pathways will take into account data from the National Health Data System (i.e. healthcare consumption). These data will then be aggregated and structured to form time sequences representing the care pathways (and classes of care pathways) of patients using the optimal matching method. These sequences will include several medical events such as consultations, treatments, hospitalizations for example. This will provide us with a simplified but detailed representation of care trajectories. The individual care sequences thus constructed will allow us to carry out sequence analyzes aimed at creating patient clusters.

    12 months

Study Arms (1)

Patients with oral cavity cancer or maxillary and/or oropharynx cancer

Patients with oral cavity cancer or maxillary and/or oropharynx cancer eligible for treatment by surgery requiring a mandibulectomy or segmental maxillectomy and having a free bone flap for facial reconstruction.

Other: Questionnaires

Interventions

Quality of life questionnaires, questionnaires for assessing functional results, micro-costing questionnaire, informal support assessment questionnaires

Patients with oral cavity cancer or maxillary and/or oropharynx cancer

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participation in the protocol will be offered to all patients meeting the eligibility criteria during the 3-year inclusion period. It is planned to include 200 operated patients, including 50 treated by maxillectomy and 150 treated by mandibulectomy. Nine French cancer centers and university hospitals will participate in the project: the University Hospitals of Toulouse, Amiens, Rouen, Lille, Montpellier, Nantes, the Gustave Roussy Institute, the Antoine Lacassagne Center (Nice) and the Hospices Civil de Lyon.

You may qualify if:

  • Patient with oral cavity cancer or maxillary and/or oropharynx cancer
  • Eligible for treatment by surgery requiring a mandibulectomy or segmental maxillectomy and having a free bone flap for facial reconstruction.
  • Patient whose disease is classified Stage cT4a, N0 to N3, M0
  • Treatment with a feasible curative aim (no contraindication to optimal treatment such as surgery or chemotherapy at a curative dose)
  • Age greater than or equal to 18 years
  • Patient affiliated to a Social Security scheme in France
  • Patient having given written informed consent
  • Patient having had previous radiotherapy
  • Patient with severe coagulation disorders
  • Patients deprived of liberty or under legal protection regime (curatorship and guardianship, safeguard of justice)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

University hospital of Amiens- Picardie

Amiens, 80054, France

NOT YET RECRUITING

University hospital of Lille

Lille, 59037, France

NOT YET RECRUITING

Hospices Civils de Lyon

Lyon, 69004, France

NOT YET RECRUITING

University hospital of Montpellier

Montpellier, 34090, France

NOT YET RECRUITING

University hospital of Nantes

Nantes, 44093, France

NOT YET RECRUITING

Centre Antoine Lacassagne

Nice, 06189, France

NOT YET RECRUITING

University hospital of Rouen

Rouen, 76000, France

NOT YET RECRUITING

University hospital of Toulouse

Toulouse, 31059, France

RECRUITING

Institut Gustave Roussy

Villejuif, 94805, France

NOT YET RECRUITING

MeSH Terms

Conditions

Head and Neck Neoplasms

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasms

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Agnès DUPRET-BORIES

    University Hospital, Toulouse

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Agnès DUPRET-BORIES

CONTACT

Camille Dumon

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 7, 2025

First Posted

January 13, 2025

Study Start

September 3, 2025

Primary Completion (Estimated)

December 1, 2029

Study Completion (Estimated)

December 1, 2029

Last Updated

September 22, 2025

Record last verified: 2025-09

Locations